Since immunotherapy began in 2011, immune checkpoint inhibitor (ICI) therapy based on the programmed death protein 1 (PD-1)/programmed death protein ligand 1 (PD-L1) signaling pathway has played an increasingly important role in cancer treatment [1]. Here, CD274 is linked to cancer.